Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,022,500
-$1,527,500 QoQ
Shares Held
3,250,000
0.0% QoQ
Ownership
0.869%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#16
of 220 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $49,746,703 across 12 Drug Manufacturers - Specialty & Generic names. BHC ranks #2 (32.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
347,374 | $24,962,294 | |
| 2 | BHC |
Bausch Health Companies Inc.
This page
|
3,250,000 | $16,022,500 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,329 | $2,887,412 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
13,870 | $2,337,649 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
56,337 | $1,908,697 | |
| 6 | VTRS |
Viatris Inc
|
58,191 | $924,071 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
4,951 | $549,263 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,500 | $86,675 |
All Filings in BHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,022,500 | 3,250,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,550,000 | 3,250,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,587,500 | 3,250,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,962,500 | 3,250,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $33,966,000 | 5,100,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,702,000 | 6,600,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $53,196,000 | 6,600,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,856,000 | 6,600,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||